An increase in cellular viability was observed in irradiated LNCaP and CWR22Rv1 cells with upregulated EDEM3 compared to control cells, suggesting that high levels of EDEM3 might confer radio-resistance to prostate cancer cells. Here, EDEM3 is linked to prostate cancer.